The study of placentrex and hydrocortisone as an adjunct treatment in oral submucous fibrosis

BACKGROUND: Submucous fibrosis with a high incidence rate in the Indian subcontinent is a devastating disease affecting the oral cavity and oropharynx. AIMS AND OBJECTIVE: To evaluate the efficacy of injection placentrex and injection hydrocortisone in oral submucous fibrosis patients in increasing...

Descripción completa

Detalles Bibliográficos
Autores principales: Kisave, Parag, Shekhar, Vijay, Babu, Prasoon S., Hussaini, Syed W. U., Bhanot, Rishabh, Kumar, Abhinav, Tiwari, Rahul V. C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7380742/
https://www.ncbi.nlm.nih.gov/pubmed/32754522
http://dx.doi.org/10.4103/jfmpc.jfmpc_268_20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7380742/
https://www.ncbi.nlm.nih.gov/pubmed/32754522
http://dx.doi.org/10.4103/jfmpc.jfmpc_268_20

Ejemplares similares